Askin Tumor: Clinical Trials

3 trials for Askin Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Askin Tumor: new trials by email Literature Review of Askin Tumor trials Research Report on Askin Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
Laboratory Biomarker Analysis - Askin Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
CompletedChildren's Oncology Group9082008-02-042023-10-03
QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors
AMG 479 - Askin's Tumors, Desmoplastic Small Round Cell Tumors
Phase 2CompletedNantCell, Inc.382007-10-012016-10-27
Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
cyclophosphamide, doxorubicin hydrochloride, etoposide - Kidney Cancer, Sarcoma
Phase 2CompletedMemorial Sloan Kettering Cancer Center1990-05-012013-06-20

Narrower conditions

Neuroectodermal Tumors, Primitive, Peripheral (2)  ·  Sarcoma (2)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Insulin-Like Growth Factor I, Resistance To (1)  ·  Kidney Neoplasms (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Osteosarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Wilms Tumor (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neuroectodermal Tumors, Primitive (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)

Interventions

Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Ifosfamide (1)  ·  Radiotherapy (1)  ·  Vincristine (1)  ·  ganitumab (1)

Sponsors

Children's Oncology Group (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  NantCell, Inc. (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Brian H. Kushner, MD (1)  ·  Stephen L Lessnick (1)

Results publications

PMID 7595741, PMID 8622067

NIH funding

U10CA098543 (1), UG1CA189958 (1)